Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DHH antisense RNA 1 (DHH-AS1) is an antisense long non-coding RNA transcribed from the locus of the Desert hedgehog (DHH) gene. Antisense lncRNAs in general are known to regulate gene expression at multiple levels, frequently impacting neighboring or overlapping protein-coding genes through mechanisms such as transcriptional interference, chromatin modification, epigenetic regulation, mRNA stability, or direct RNA duplex formation[1][2][3]. However, as of now there is no published functional characterization, disease association, or established therapeutic relevance for DHH-AS1 itself. The Desert hedgehog gene encodes a protein important for developmental signaling, but the antisense RNA transcribed from the locus (DHH-AS1) is currently a gene annotation with no experimentally validated biological function or direct role in disease. In general, antisense lncRNAs have emerged as important regulators in cancer and other diseases—often studied as modulators of their sense gene—but for DHH-AS1 specifically, further research is needed to confirm its activity, mechanisms, and clinical implications[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DHH antisense RNA 1 (DHH-AS1).